Recently, Professor Ruan Changshun, Researcher at the Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Secretary-General of the Advanced Manufacturing Branch of the Chinese Society for Biomaterials, and Independent Director of Shenzhen eSUN Industrial Co., Ltd., visited the ESUN INNOVATION CENTER and the eSUNMed Wuhan Branch for inspection and guidance.
Mr. Chen Rui, Deputy General Manager of Shenzhen eSUN Industrial Co., Ltd., gave a comprehensive presentation on the company’s technology R&D platform and its four major business sectors. He highlighted the company’s latest progress in biomaterial synthesis and modification, fiber applications, 3D printing materials, and biomedical materials, and provided a detailed overview of the R&D system of the technology center, showcasing the company’s full-industry-chain development path from core material innovation to diversified market applications.
Subsequently, Dr. Xie Qing, Deputy General Manager of eSUNMed, introduced the company’s product development in medical aesthetics and biomedical materials, with a particular focus on innovative achievements and technological breakthroughs in biomedical polymer microspheres. Both parties engaged in an in-depth discussion on material property optimization and clinical application prospects.
After gaining a thorough understanding of the R&D progress, Professor Ruan highly praised eSUNMed’s technical achievements in the field of biomedical polymer microspheres. During the on-site inspection, he offered specific suggestions regarding material preparation processes and performance optimization, emphasizing the importance of strengthening research on the application of biodegradable microspheres in the medical aesthetics field.
Professor Ruan also expressed his recognition of eSUN’s full-industry-chain layout in biomaterial synthesis, modification, and application development, and looked forward to further refining the industrial chain from material innovation to product transformation in the future, working together to advance the industrialization of high-end medical aesthetic materials.